RxDoctor Payments Data

Robert Delbene, DPM

Podiatrist · Waynesville, NCNPI 1023004447

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,632 of the $3,240 with a category attached, or 81.2%. It is spread thinly across 21 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.

$3,240in general payments, 2019–2025

Across 71 payments — averaging $45.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Peerless Surgical Inc.$646
  • Amgen$560
  • Smith+Nephew$451
  • Treace Medical Concepts, Inc.$206
  • Averitas Pharma Inc.$181
  • Linvatec Corporation$164
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$2,63281%
  • Education$60819%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,240 in reported general payments places this provider in the 65th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$230,746
Medicare patients
711
Services billed
24,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl33$574
Meloxicam50$239
Doxycycline Hyclate23$178
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$111
Methylprednisolone22$98
Gabapentin12$69

Paid to pharmacies, not to this prescriber.

Other podiatrist in Waynesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →